MedPath

To study the management of ashwatha ghanavati in vatarakta (gout)

Phase 2
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2024/06/068246
Lead Sponsor
Dr. Komal Popat Sonawane
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having clinical symptoms of vatarakta like pain in joint,swelling,burning sensation,tenderness at joints , stiffness,local colour changes

Sr uric acid level 3-12mg/dl

Exclusion Criteria

Patients with severe form of other systemic disorder like cardiac disease ,renal failure ,CAV will be excluded.

Pregnant women and lactating mother

Injury requiring surgical interventions

Any condition interfering the course of treatment were excluded

Secondary hyperuricemia due to leukemia ,lypoma,polycythemia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath